Review



mouse gp100 peptide as-64752  (AnaSpec)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    AnaSpec mouse gp100 peptide as-64752
    Analysis of OT-1 splenocytes after treatment with a conventional protocol or PDCNP-Ab (n = 3 biologically independent samples). a Analysis of T-cell activation markers, including CD69, TNF-α, and IFN-γ, and memory T cell phenotypes. b Analysis of T-cell proliferation and differentiation into T CM or T EM . c Scheme of testing adoptive cell therapy with PDCNP-Ab loaded OT-1 cells in mice bearing flank B16F10-OVA tumors. PBS or OT-1 splenocytes (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/j90x668 . d Animal survival (left) and tumor growth curves (right). e Scheme of testing adoptive cell therapy with PDCNP-Ab-loaded <t>PMEL-1</t> T cells. The study was conducted in a metastatic tumor model established with i.v. administered B16F10-fluc cells. PBS or splenocytes from PMEL-1 mice (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/d83g701 . f Whole-body bioluminescence images taken at different time points to monitor tumor establishment and metastasis. g Left, tumor growth curves, based on region-of-interest (ROI) analysis of BLI images; right, animal survival curves. Data represent mean ± SD. Statistical difference was evaluated using a one-way ANOVA test in ( a – b ); Mantel-Cox test in ( d , g ) (survival); and unpaired t-test (one-tailed) in ( d, g ) (tumor volume). Source data underlying ( a – b, d and g ) are provided in a file.
    Mouse Gp100 Peptide As 64752, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse gp100 peptide as-64752/product/AnaSpec
    Average 90 stars, based on 1 article reviews
    mouse gp100 peptide as-64752 - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Calcium nanoparticles target and activate T cells to enhance anti-tumor function"

    Article Title: Calcium nanoparticles target and activate T cells to enhance anti-tumor function

    Journal: Nature Communications

    doi: 10.1038/s41467-024-54402-y

    Analysis of OT-1 splenocytes after treatment with a conventional protocol or PDCNP-Ab (n = 3 biologically independent samples). a Analysis of T-cell activation markers, including CD69, TNF-α, and IFN-γ, and memory T cell phenotypes. b Analysis of T-cell proliferation and differentiation into T CM or T EM . c Scheme of testing adoptive cell therapy with PDCNP-Ab loaded OT-1 cells in mice bearing flank B16F10-OVA tumors. PBS or OT-1 splenocytes (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/j90x668 . d Animal survival (left) and tumor growth curves (right). e Scheme of testing adoptive cell therapy with PDCNP-Ab-loaded PMEL-1 T cells. The study was conducted in a metastatic tumor model established with i.v. administered B16F10-fluc cells. PBS or splenocytes from PMEL-1 mice (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/d83g701 . f Whole-body bioluminescence images taken at different time points to monitor tumor establishment and metastasis. g Left, tumor growth curves, based on region-of-interest (ROI) analysis of BLI images; right, animal survival curves. Data represent mean ± SD. Statistical difference was evaluated using a one-way ANOVA test in ( a – b ); Mantel-Cox test in ( d , g ) (survival); and unpaired t-test (one-tailed) in ( d, g ) (tumor volume). Source data underlying ( a – b, d and g ) are provided in a file.
    Figure Legend Snippet: Analysis of OT-1 splenocytes after treatment with a conventional protocol or PDCNP-Ab (n = 3 biologically independent samples). a Analysis of T-cell activation markers, including CD69, TNF-α, and IFN-γ, and memory T cell phenotypes. b Analysis of T-cell proliferation and differentiation into T CM or T EM . c Scheme of testing adoptive cell therapy with PDCNP-Ab loaded OT-1 cells in mice bearing flank B16F10-OVA tumors. PBS or OT-1 splenocytes (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/j90x668 . d Animal survival (left) and tumor growth curves (right). e Scheme of testing adoptive cell therapy with PDCNP-Ab-loaded PMEL-1 T cells. The study was conducted in a metastatic tumor model established with i.v. administered B16F10-fluc cells. PBS or splenocytes from PMEL-1 mice (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/d83g701 . f Whole-body bioluminescence images taken at different time points to monitor tumor establishment and metastasis. g Left, tumor growth curves, based on region-of-interest (ROI) analysis of BLI images; right, animal survival curves. Data represent mean ± SD. Statistical difference was evaluated using a one-way ANOVA test in ( a – b ); Mantel-Cox test in ( d , g ) (survival); and unpaired t-test (one-tailed) in ( d, g ) (tumor volume). Source data underlying ( a – b, d and g ) are provided in a file.

    Techniques Used: Activation Assay, One-tailed Test



    Similar Products

    mouse gp100 peptide as-64752  (AnaSpec)
    90
    AnaSpec mouse gp100 peptide as-64752
    Analysis of OT-1 splenocytes after treatment with a conventional protocol or PDCNP-Ab (n = 3 biologically independent samples). a Analysis of T-cell activation markers, including CD69, TNF-α, and IFN-γ, and memory T cell phenotypes. b Analysis of T-cell proliferation and differentiation into T CM or T EM . c Scheme of testing adoptive cell therapy with PDCNP-Ab loaded OT-1 cells in mice bearing flank B16F10-OVA tumors. PBS or OT-1 splenocytes (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/j90x668 . d Animal survival (left) and tumor growth curves (right). e Scheme of testing adoptive cell therapy with PDCNP-Ab-loaded <t>PMEL-1</t> T cells. The study was conducted in a metastatic tumor model established with i.v. administered B16F10-fluc cells. PBS or splenocytes from PMEL-1 mice (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/d83g701 . f Whole-body bioluminescence images taken at different time points to monitor tumor establishment and metastasis. g Left, tumor growth curves, based on region-of-interest (ROI) analysis of BLI images; right, animal survival curves. Data represent mean ± SD. Statistical difference was evaluated using a one-way ANOVA test in ( a – b ); Mantel-Cox test in ( d , g ) (survival); and unpaired t-test (one-tailed) in ( d, g ) (tumor volume). Source data underlying ( a – b, d and g ) are provided in a file.
    Mouse Gp100 Peptide As 64752, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse gp100 peptide as-64752/product/AnaSpec
    Average 90 stars, based on 1 article reviews
    mouse gp100 peptide as-64752 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Analysis of OT-1 splenocytes after treatment with a conventional protocol or PDCNP-Ab (n = 3 biologically independent samples). a Analysis of T-cell activation markers, including CD69, TNF-α, and IFN-γ, and memory T cell phenotypes. b Analysis of T-cell proliferation and differentiation into T CM or T EM . c Scheme of testing adoptive cell therapy with PDCNP-Ab loaded OT-1 cells in mice bearing flank B16F10-OVA tumors. PBS or OT-1 splenocytes (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/j90x668 . d Animal survival (left) and tumor growth curves (right). e Scheme of testing adoptive cell therapy with PDCNP-Ab-loaded PMEL-1 T cells. The study was conducted in a metastatic tumor model established with i.v. administered B16F10-fluc cells. PBS or splenocytes from PMEL-1 mice (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/d83g701 . f Whole-body bioluminescence images taken at different time points to monitor tumor establishment and metastasis. g Left, tumor growth curves, based on region-of-interest (ROI) analysis of BLI images; right, animal survival curves. Data represent mean ± SD. Statistical difference was evaluated using a one-way ANOVA test in ( a – b ); Mantel-Cox test in ( d , g ) (survival); and unpaired t-test (one-tailed) in ( d, g ) (tumor volume). Source data underlying ( a – b, d and g ) are provided in a file.

    Journal: Nature Communications

    Article Title: Calcium nanoparticles target and activate T cells to enhance anti-tumor function

    doi: 10.1038/s41467-024-54402-y

    Figure Lengend Snippet: Analysis of OT-1 splenocytes after treatment with a conventional protocol or PDCNP-Ab (n = 3 biologically independent samples). a Analysis of T-cell activation markers, including CD69, TNF-α, and IFN-γ, and memory T cell phenotypes. b Analysis of T-cell proliferation and differentiation into T CM or T EM . c Scheme of testing adoptive cell therapy with PDCNP-Ab loaded OT-1 cells in mice bearing flank B16F10-OVA tumors. PBS or OT-1 splenocytes (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/j90x668 . d Animal survival (left) and tumor growth curves (right). e Scheme of testing adoptive cell therapy with PDCNP-Ab-loaded PMEL-1 T cells. The study was conducted in a metastatic tumor model established with i.v. administered B16F10-fluc cells. PBS or splenocytes from PMEL-1 mice (8 × 10 6 /mouse), activated with either a conventional protocol or with PDCNP-Ab, were fused i.v. into animals 7 days after tumor inoculation (n = 5 mice). Created in BioRender. Li, J. (2024) https://BioRender.com/d83g701 . f Whole-body bioluminescence images taken at different time points to monitor tumor establishment and metastasis. g Left, tumor growth curves, based on region-of-interest (ROI) analysis of BLI images; right, animal survival curves. Data represent mean ± SD. Statistical difference was evaluated using a one-way ANOVA test in ( a – b ); Mantel-Cox test in ( d , g ) (survival); and unpaired t-test (one-tailed) in ( d, g ) (tumor volume). Source data underlying ( a – b, d and g ) are provided in a file.

    Article Snippet: PMEL-1 splenocytes were collected from PMEL-1 mice as previously described and activated by incubation with mouse gp100 peptide (10 μg/mL, AnaSpec, AS-64752) and mouse IL-2 (10 ng/mL) for 5 days.

    Techniques: Activation Assay, One-tailed Test